Citigroup Inc Milestone Pharmaceuticals Inc. Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Citigroup Inc holds 329 shares of MIST stock, worth $753. This represents 0.0% of its overall portfolio holdings.
Number of Shares
329Holding current value
$753% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIST
# of Institutions
50Shares Held
26.2MCall Options Held
47KPut Options Held
17K-
Black Rock Inc. New York, NY4.97MShares$11.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.7MShares$6.19 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$6.09 Million2.16% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$5.74 Million0.1% of portfolio
-
Orbimed Advisors LLC San Diego, CA2MShares$4.58 Million0.13% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $68.7M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...